Page last updated: 2024-08-22

angiotensin ii and Cardiomyopathy, Hypertrophic

angiotensin ii has been researched along with Cardiomyopathy, Hypertrophic in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (13.73)	18.7374
1990's	11 (21.57)	18.2507
2000's	19 (37.25)	29.6817
2010's	13 (25.49)	24.3611
2020's	1 (1.96)	2.80

Authors

Authors	Studies
Du, Y; Guan, C; Huang, Z; Li, P; Wang, K; Zhang, Y; Zhou, M	1
Chen, RJ; Chen, YF; Day, CH; Huang, CY; Lee, NH; Lin, CH; Rajendran, P; Viswanadha, VP; Yang, JJ	1
He, W; Jiang, H; Zhang, C	1
Li, Q; Lin, L; Liu, X; Ni, Y; Qin, S; Wei, J; Zhang, C	1
Feng, YQ; Geng, QS; Hu, ZQ; Huang, L; Huang, YQ; Shan, ZX; Yu, XJ; Zhu, JN	1
Chen, Y; Li, C; Liu, J; Liu, Y; Luo, C; Sun, D; Wang, Z; Wen, S	1
Chen, Y; Iwaya, S; Oikawa, M; Takeishi, Y	1
Basu, R; Fan, D; Fernandez-Patron, C; Kassiri, Z; Oudit, GY; Patel, V; Samokhvalov, V; Seubert, JM; Shen, M; Takawale, A; Wang, X	1
Schlüter, KD; Wenzel, S	1
Kaludercic, N; Paolocci, N; Reggiani, C	1
Chang, SK; Sun, CW; Yao, FR	1
Gao, S; Kim, JH; Kim, SH; Oh, YB; Park, WH; Shah, A	1
Bai, H; Li, L; Liu, J	1
Chandrasekar, B; Delafontaine, P; Prabhu, SD; Shanmugam, P; Valente, AJ; Venkatesan, B; Yoshida, T	1
Marber, MS; Martin, ED	1
Hoit, BD; Lee, HG; Liner, A; Richardson, SL; Smith, MA; Wolfram, JA; Zhu, X	1
Sun, YK; Wang, SR; Yu, Y	1
Lai, WY; Liu, Y; Ouyang, P; Wang, MH; Xu, DL	1
deChâtel, R; Földes, G; Ilves, M; Lakó-Futó, Z; Leskinen, H; Ruskoaho, H; Sármán, B; Skoumal, R; Szokodi, I; Tokola, H; Tóth, M; Vuolteenaho, O	1
Fujita, T; Goto, A; Hirata, Y; Nagai, R; Nishimatsu, H; Oba, S; Omata, M; Satonaka, H; Suzuki, E; Takeda, R	1
Huang, L; Yang, YJ; Yu, LJ; Zhu, SJ	1
Averill, DB; Brosnihan, KB; Ferrario, CM; Gallagher, PE; Ishiyama, Y; Tallant, EA	1
Brandes, RP; Busse, R; Geiger, H; Jung, O; Pedrazzini, T; Schreiber, JG	1
Fujiwara, H; Nishigaki, K	1
Matsuda, H; Matsumoto, K; Mizuno, S; Nakamura, T; Sawa, Y	1
Eto, T; Imamura, T; Kitamura, K; Kuwasako, K; Onitsuka, H; Yamaga, J	1
Ferrario, CM; Grobe, JL; Huentelman, MJ; Katovich, MJ; Mecca, AP; Raizada, MK; Stewart, JM; Vazquez, J	1
Akazawa, H; Komuro, I; Yasuda, N	1
de Resende, MM; Greene, AS; Kriegel, AJ	1
Han, J; Jung, ID; Kang, SH; Kim, N; Ko, JH; Park, WS; Park, YM; Son, YK; Warda, M	1
Kanno, M; Kitabatake, A; Kusaka, M; Nakaya, H; Sakuma, I; Tohse, N; Uemura, H; Yamashita, T; Yasuda, H	1
Sakata, Y	1
Komuro, I; Yamazaki, T; Yazaki, Y	1
Katz, AM	1
Yamazaki, T; Yazaki, Y	1
Böhm, M; Ettelbrück, S; Flesch, M; Knorr, A; Pinto, Y; Schiffer, F; Stasch, JP; Zolk, O	1
Christy, DH; Davison, G; Hall, CS; Lanza, GM; Miller, JG; Scott, MJ; Wickline, SA	1
Erdmann, J; Fleck, E; Guse, M; Kallisch, H; Regitz-Zagrosek, V	1
Ito, S; Matsuoka, M; Mishiro, Y; Oki, T; Onose, Y; Tabata, T; Wakatsuki, T; Yamada, H	1
Zhan, CD	1
Yamashita, T	1
Hanada, H; Hirota, Y; Kawamura, K; Suwa, M; Yoneda, Y	1
Apstein, CS; Dzau, VJ; Hirsch, AT; Lorell, BH; Schunkert, H; Tang, SS	1
Imaizumi, T; Nakamura, M; Sueishi, K; Takeshita, A; Yamamoto, K	1
Hausdorf, G; Nienaber, CA; Siglow, V	1
Imaizumi, T; Nakamura, M; Takeshita, A; Yamamoto, K	1
Auger, P; Marquis, Y; Wigle, ED	2
Adelman, AG; Auger, P; Marquis, Y; Wigle, ED	1
Baldelli, P; Malfanti, PL; Massi, A; Rosselli, M; Salvatore, L; Santini, L; Zerauschek, M	1
Adelman, AG; Bigelow, WG; Felderhof, CH; Trimble, AS; Wigle, ED	1

Reviews

6 review(s) available for angiotensin ii and Cardiomyopathy, Hypertrophic

Article	Year
Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacology & therapeutics, 2008, Volume: 119, Issue:3 Topics: Angiotensin II; Animals; Apoptosis; Cardiomyopathy, Hypertrophic; Humans; Models, Biological; Myocytes, Cardiac; Reactive Oxygen Species; Receptors, Angiotensin; Signal Transduction	2008
[Natriuretic peptides and cardiomyopathy]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Biomarkers; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Humans; Natriuretic Peptide, Brain	2004
[Mechanical stress in cardiovascular remodeling]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomyopathy, Hypertrophic; Cardiovascular System; Humans; Mechanoreceptors; Receptor, Angiotensin, Type 1; Stress, Mechanical	2006
[Hypertrophic responses to mechanical stretch in cardiac myocytes]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1996, Volume: 41, Issue:1 Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Genes, fos; Heart; Humans; Myocardium; Protein Kinase C; Sodium Channels; Stress, Mechanical	1996
The cardiomyopathy of overload: an unnatural growth response. European heart journal, 1995, Volume: 16 Suppl O Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Bradykinin; Cardiomyopathy, Hypertrophic; Cell Division; Growth Substances; Heart Failure; Hemodynamics; Humans; Myocardium; Nitrates; Vasodilator Agents	1995
[Molecular mechanism of cardiac hypertrophy and dysfunction]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:8 Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Endothelin-1; Heart Failure; Humans; Hypertension; Proto-Oncogene Proteins c-raf; Rats; Signal Transduction; Stress, Mechanical	1997

Other Studies

45 other study(ies) available for angiotensin ii and Cardiomyopathy, Hypertrophic

Article	Year
IRX2 activated by jumonji domain-containing protein 2A is crucial for cardiac hypertrophy and dysfunction in response to the hypertrophic stimuli. International journal of cardiology, 2023, Jan-15, Volume: 371 Topics: Angiotensin II; Animals; beta Catenin; Cardiomegaly; Cardiomyopathy, Hypertrophic; Homeodomain Proteins; Jumonji Domain-Containing Histone Demethylases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Transcription Factors; Ventricular Dysfunction	2023
Tanshinone IIA Inhibits β-Catenin Nuclear Translocation and IGF-2R Activation via Estrogen Receptors to Suppress Angiotensin II-Induced H9c2 Cardiomyoblast Cell Apoptosis. International journal of medical sciences, 2017, Volume: 14, Issue:12 Topics: Abietanes; Angiotensin II; Animals; Apoptosis; beta Catenin; Cardiomyopathy, Hypertrophic; Cell Line; Cell Nucleus; Drugs, Chinese Herbal; Humans; Myocytes, Cardiac; Phosphorylation; Protein Transport; Rats; Receptor, IGF Type 2; Receptors, Estrogen; Salvia miltiorrhiza; Signal Transduction	2017
The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats. Medical science monitor : international medical journal of experimental and clinical research, 2018, Sep-10, Volume: 24 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; China; Flavonoids; Heart Ventricles; Medicine, Tibetan Traditional; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction	2018
ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation. BMC molecular and cell biology, 2019, 06-14, Volume: 20, Issue:1 Topics: Angiotensin II; Animals; Butadienes; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cell Enlargement; Cell Line; Connective Tissue Growth Factor; Disease Models, Animal; ErbB Receptors; Heart Ventricles; MAP Kinase Signaling System; Myocytes, Cardiac; Nitriles; Phosphorylation; Rats; Receptors, G-Protein-Coupled; Signal Transduction	2019
MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2. Life sciences, 2019, Sep-01, Volume: 232 Topics: 3' Untranslated Regions; Angiotensin II; Animals; Basic Helix-Loop-Helix Transcription Factors; Cardiomegaly; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Heart Defects, Congenital; Heart Failure; Heart Ventricles; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Myocytes, Cardiac; RNA, Small Interfering; Signal Transduction; Up-Regulation	2019
Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene DNA and cell biology, 2019, Volume: 38, Issue:8 Topics: 3' Untranslated Regions; Adult; Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Case-Control Studies; Female; Gene Expression Regulation; GTP Phosphohydrolases; Humans; Male; Membrane Proteins; MicroRNAs; Middle Aged; Mitochondrial Proteins; Myocytes, Cardiac; Rats, Wistar	2019
Phosphodiesterase 3A1 protects the heart against angiotensin II-induced cardiac remodeling through regulation of transforming growth factor-β expression. International heart journal, 2014, Volume: 55, Issue:2 Topics: Angiotensin II; Animals; Blotting, Western; Cardiomyopathy, Hypertrophic; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Echocardiography; Heart Ventricles; Mice; Mice, Transgenic; Transforming Growth Factor beta; Vasoconstrictor Agents; Ventricular Remodeling	2014
A Disintegrin and Metalloprotease-17 Regulates Pressure Overload-Induced Myocardial Hypertrophy and Dysfunction Through Proteolytic Processing of Integrin β1. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 68, Issue:4 Topics: ADAM17 Protein; Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cells, Cultured; Disease Models, Animal; Disintegrins; Echocardiography, Doppler; Hypertension; Hypertrophy, Left Ventricular; Mice; Mice, Knockout; Myocytes, Cardiac; Proteolysis; Random Allocation; Rats; Ventricular Dysfunction, Left	2016
Genes, geography and geometry: the "critical mass" in hypertrophic cardiomyopathy. The Journal of molecular diagnostics : JMD, 2009, Volume: 11, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cardiomyopathy, Hypertrophic; Humans; Hypertrophy, Left Ventricular; Muscle Proteins; Mutation	2009
Morton lentil extract attenuated angiotensin II-induced cardiomyocyte hypertrophy via inhibition of intracellular reactive oxygen species levels in vitro. Journal of agricultural and food chemistry, 2010, Oct-13, Volume: 58, Issue:19 Topics: Angiotensin II; Animals; Antioxidants; Cardiomyopathy, Hypertrophic; Cells, Cultured; Humans; Lens Plant; Myocytes, Cardiac; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species	2010
Endogenous angiotensin II suppresses stretch-induced ANP secretion via AT1 receptor pathway. Peptides, 2011, Volume: 32, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophic; Extracellular Fluid; Gene Expression; Heart Atria; Hypertension, Renal; Imidazoles; Losartan; Male; Myocardial Contraction; Peptide Fragments; Perfusion; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reflex, Stretch	2011
[Alterations of cardiac G a q/11 in two-kidney one-slip renal hypertensive and spontaneously hypertensive rats]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2003, Volume: 19, Issue:2 Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Hypertension, Renal; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar	2003
Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy. Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:6 Topics: Angiotensin II; Animals; beta Catenin; Cardiomyopathy, Hypertrophic; CCN Intercellular Signaling Proteins; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Intracellular Signaling Peptides and Proteins; Male; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Protein Binding; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger; Superoxides; TCF Transcription Factors; Vasoconstrictor Agents	2011
Will o' the WISP1: a novel mediator of Ang-II induced cardiomyocyte hypertrophy. Journal of molecular and cellular cardiology, 2011, Volume: 50, Issue:6 Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; CCN Intercellular Signaling Proteins; Humans; Intracellular Signaling Peptides and Proteins; Myocytes, Cardiac; Proto-Oncogene Proteins; Vasoconstrictor Agents	2011
The role of E2F1 in the development of hypertrophic cardiomyopathy. International journal of clinical and experimental pathology, 2011, Jun-20, Volume: 4, Issue:5 Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cell Cycle; E2F1 Transcription Factor; Gene Expression Regulation; Humans; Isoproterenol; Male; Mice; Mice, Knockout; Mice, Transgenic; Myocytes, Cardiac; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents	2011
[Effects of ligustrazine on the mitochondrial structure and functions in the process myocardial hypertrophy]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2012, Volume: 32, Issue:5 Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cells, Cultured; Electron Transport Complex IV; Mitochondria, Heart; Monoamine Oxidase; Myocytes, Cardiac; Pyrazines; Rats; Rats, Sprague-Dawley	2012
[Regulation of cyclin-dependent kinase inhibitors by mitogen-activated protein kinase in angiotensin II-stimulated vascular smooth muscle cell hypertrophy]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2002, Volume: 22, Issue:2 Topics: Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Disease Models, Animal; Male; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Tumor Suppressor Proteins	2002
Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart. Circulation, 2003, Nov-11, Volume: 108, Issue:19 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophic; Fibroblast Growth Factor 1; Gene Expression Regulation; Genes, fos; Heart Rate; Hypertension; Imidazoles; Infusion Pumps, Implantable; Losartan; Male; Natriuretic Peptide, Brain; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A	2003
Calcineurin promotes the expression of monocyte chemoattractant protein-1 in vascular myocytes and mediates vascular inflammation. Circulation research, 2004, Mar-19, Volume: 94, Issue:5 Topics: Angiotensin II; Animals; Calcineurin; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomyopathy, Hypertrophic; Cells, Cultured; Chemokine CCL2; Cyclosporine; Femoral Artery; Gene Expression Regulation; Humans; Hyperplasia; Imidazoles; Macrophages; MAP Kinase Kinase 6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Promoter Regions, Genetic; Protein Biosynthesis; Proteins; Pyridines; Rats; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; Tetrazoles; Transcription, Genetic; Tunica Intima; Valine; Valsartan; Vasculitis	2004
[CaN-NFAT3 signal pathway: a crucial hinge relates Ca2+ signal with cardiomyocyte hypertrophy]. Zhonghua nei ke za zhi, 2004, Volume: 43, Issue:1 Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Calcium; Calpain; Cardiomyopathy, Hypertrophic; Cells, Cultured; DNA-Binding Proteins; GATA4 Transcription Factor; Myocytes, Cardiac; NFATC Transcription Factors; Nuclear Proteins; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Transcription Factors	2004
Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Coronary Vessels; Disease Models, Animal; Enzyme Induction; Imidazoles; Ligation; Losartan; Male; Myocardial Infarction; Myocardium; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ventricular Remodeling	2004
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation, 2004, Apr-13, Volume: 109, Issue:14 Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcholine; Angiotensin II; Animals; Antioxidants; Aorta; Bacterial Toxins; Cardiomyopathy, Hypertrophic; Cytochromes b; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; ErbB Receptors; Glycoproteins; Hypertension, Renovascular; Indoles; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Organ Culture Techniques; Polyethylene Glycols; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Superoxide Dismutase; Superoxides; Tyrphostins; Vasodilation; Vasodilator Agents	2004
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. American journal of physiology. Heart and circulatory physiology, 2005, Volume: 288, Issue:5 Topics: Angiotensin II; Animals; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; CHO Cells; Cricetinae; Fibrosis; Gene Expression; Hepatocyte Growth Factor; Humans; Male; Mesocricetus; Myocytes, Cardiac; Proto-Oncogene Proteins c-met; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ultrasonography; Vasoconstrictor Agents; Ventricular Remodeling	2005
Angiotensin II stimulates cardiac adrenomedullin production and causes accumulation of mature adrenomedullin independently of hemodynamic stress in vivo. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2005, Volume: 37, Issue:5 Topics: Adrenomedullin; Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Gene Expression Regulation; Heart Ventricles; Male; Myocardium; Peptides; Rats; Vasoconstrictor Agents	2005
Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Experimental physiology, 2005, Volume: 90, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Animals, Newborn; Blood Pressure; Body Weight; Carboxypeptidases; Cardiomyopathy, Hypertrophic; Endomyocardial Fibrosis; Gene Expression; Genetic Vectors; Heart; Lentivirus; Mice; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Transduction, Genetic	2005
Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy. Journal of cardiovascular pharmacology, 2006, Volume: 48, Issue:6 Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Injections, Subcutaneous; Myocardium; Organ Size; Random Allocation; Rats; Rats, Inbred Strains; Spironolactone; Ventricular Function, Left; Weight Loss	2006
Increased inhibition of inward rectifier K+ channels by angiotensin II in small-diameter coronary artery of isoproterenol-induced hypertrophied model. Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:8 Topics: Angiotensin II; Animals; Blotting, Western; Cardiomyopathy, Hypertrophic; Cells, Cultured; Coronary Vessels; Disease Models, Animal; Electrophysiology; Endothelium, Vascular; Male; Muscle, Smooth, Vascular; Potassium Channels, Inwardly Rectifying; Probability; Rabbits; Random Allocation; Reference Values; Sensitivity and Specificity; Vasoconstrictor Agents; Vasodilation	2007
Depressed responsiveness to angiotensin II in ventricular myocytes of hypertrophic cardiomyopathic Syrian hamster. Journal of molecular and cellular cardiology, 1994, Volume: 26, Issue:11 Topics: Action Potentials; Angiotensin II; Animals; Calcium; Cardiomyopathy, Hypertrophic; Cricetinae; Heart Ventricles; Mesocricetus; Myocardial Contraction; Papillary Muscles; Receptors, Angiotensin; Renin-Angiotensin System	1994
[Tissue factors contributing to cardiac hypertrophy in cardiomyopathic hamsters (BIO14.6): involvement of transforming growth factor-beta 1 and tissue renin-angiotensin system in the progression of cardiac hypertrophy]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1993, Volume: 68, Issue:1 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; Cricetinae; Guinea Pigs; Male; Mesocricetus; Myocardium; Peptidyl-Dipeptidase A; Phosphatidylinositols; Renin-Angiotensin System; RNA, Messenger; Transforming Growth Factor beta	1993
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. Journal of hypertension, 1997, Volume: 15, Issue:9 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Blotting, Western; Calcium-Transporting ATPases; Captopril; Cardiomyopathy, Hypertrophic; Diastole; Dihydropyridines; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension; Mice; Mice, Transgenic; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sarcoplasmic Reticulum; Tetrazoles	1997
Angiotensin II receptor blockade in Syrian hamster (T0-2) cardiomyopathy does not affect microscopic cardiac material properties: implications for mechanisms of tissue remodeling. Cardiovascular drugs and therapy, 1997, Volume: 11, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomyopathy, Hypertrophic; Collagen; Cricetinae; Echocardiography; Heart; Imidazoles; Male; Mesocricetus; Myocardium; Organ Size; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles	1997
Novel intronic polymorphism (+1675G/A) in the human angiotensin II subtype 2 receptor gene. Human mutation, 2000, Volume: 15, Issue:5 Topics: Angiotensin II; Cardiomyopathy, Hypertrophic; Gene Frequency; Humans; Hypertension; Introns; Polymorphism, Genetic; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2000
Use of angiotensin II stress pulsed tissue Doppler imaging to evaluate regional left ventricular contractility in patients with hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2000, Volume: 13, Issue:12 Topics: Analysis of Variance; Angiotensin II; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Case-Control Studies; Echocardiography, Doppler, Pulsed; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vasoconstrictor Agents; Ventricular Dysfunction, Left	2000
[The role of nitric oxide in the prevention of myocardial hypertrophic response and its mechanisms]. Sheng li ke xue jin zhan [Progress in physiology], 2000, Volume: 31, Issue:4 Topics: Academic Dissertations as Topic; Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cyclic GMP; Endothelin-1; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Proto-Oncogene Proteins c-fos; Rats; Ventricular Pressure	2000
[Electromechanical responsiveness to alpha 1-adrenoceptor and angiotensin II receptor stimulation in the ventricular myocardium of hypertrophied and dilated cardiomyopathic Syrian hamsters]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1992, Volume: 67, Issue:6 Topics: Action Potentials; Angiotensin II; Animals; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cricetinae; Disease Models, Animal; Electric Stimulation; In Vitro Techniques; Mesocricetus; Myocardial Contraction; Papillary Muscles; Phenylephrine; Propranolol; Receptors, Adrenergic, alpha; Receptors, Angiotensin	1992
Noninvasive detection of left ventricular diastolic dysfunction using M-mode echocardiography to assess left ventricular posterior wall kinetics in hypertrophic cardiomyopathy. The American journal of cardiology, 1992, Dec-15, Volume: 70, Issue:20 Topics: Angiotensin II; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Echocardiography; Echocardiography, Doppler; Female; Humans; Male; Middle Aged; Myocardial Contraction; Ventricular Function, Left	1992
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. The Journal of clinical investigation, 1990, Volume: 86, Issue:6 Topics: Angiotensin I; Angiotensin II; Animals; Blotting, Northern; Cardiomyopathy, Hypertrophic; Coronary Circulation; Gene Expression; Hemodynamics; Male; Myocardial Contraction; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; RNA, Messenger; Vascular Resistance	1990
Limited maximal vasodilator capacity of forearm resistance vessels in patients with hypertrophic cardiomyopathy. Heart and vessels, 1990, Volume: 5, Issue:3 Topics: Adult; Angiotensin II; Cardiomyopathy, Hypertrophic; Female; Forearm; Humans; Hyperemia; Male; Muscle, Smooth, Vascular; Plethysmography; Regional Blood Flow; Vascular Resistance; Vasodilation	1990
Effects of increasing afterload on early diastolic dysfunction in hypertrophic non-obstructive cardiomyopathy. British heart journal, 1988, Volume: 60, Issue:3 Topics: Adult; Angiotensin II; Blood Pressure; Cardiomyopathy, Hypertrophic; Diastole; Echocardiography; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction	1988
Limited maximal vasodilator capacity of forearm resistance vessels in hypertrophic cardiomyopathy. Journal of cardiology. Supplement, 1987, Volume: 16 Topics: Adult; Angiotensin II; Blood Pressure; Cardiomyopathy, Hypertrophic; Female; Forearm; Humans; Male; Middle Aged; Regional Blood Flow; Vascular Resistance; Vasodilation	1987
Muscular subaortic stenosis. The direct relation between the intraventricular pressure difference and the left ventricular ejection time. Circulation, 1967, Volume: 36, Issue:1 Topics: Amyl Nitrite; Angiotensin II; Aorta; Blood Circulation; Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Heart Ventricles; Humans; Isoproterenol; Norepinephrine	1967
Pharmacodynamics of mitral insufficiency in muscular subaortic stenosis. Canadian Medical Association journal, 1967, Aug-05, Volume: 97, Issue:6 Topics: Angiotensin II; Cardiomyopathy, Hypertrophic; Humans; Mitral Valve Insufficiency	1967
Mitral regurgitation in muscular subaortic stenosis. The American journal of cardiology, 1969, Volume: 24, Issue:5 Topics: Amyl Nitrite; Angiotensin II; Aorta; Blood Pressure; Cardiomyopathy, Hypertrophic; Dye Dilution Technique; Heart Ventricles; Humans; Indocyanine Green; Isoproterenol; Mitral Valve Insufficiency; Myocardium	1969
[Clinico-hemodynamic findings in obstructive hypertrophic myocardiopathy]. Atti della Societa italiana di cardiologia, 1968, Volume: 2 Topics: Angiotensin II; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Hemodynamics; Humans; Isoproterenol; Kinetocardiography; Phonocardiography	1968
The treatment of muscular subaortic stenosis. The Journal of thoracic and cardiovascular surgery, 1974, Volume: 68, Issue:3 Topics: Angiotensin II; Blood Pressure; Cardiomyopathy, Hypertrophic; Female; Humans; Methods; Mitral Valve Insufficiency; Postoperative Complications; Prognosis; Propranolol; Prospective Studies	1974